Management and outcomes of non small cell lung cancer involving the superior sulcus Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery Year: 2008
Role of surgery in a multidisciplinary approach for superior sulcus tumors (SST). Morbidity and prognostic factors for long-term success after resection Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery Year: 2008
The assessment of surgical treatment in middle lobe syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 490s Year: 2005
6-month follow-up in patients with advanced upper lobe predominant heterogeneous emphysema treated with endobronchial lung sealant therapy Source: Annual Congress 2011 - Treatment beyond inhalers: endoscopic lung volume reduction Year: 2011
Impact on survival of station 9 and necessity of inferior pulmonary ligament dissection in upper lobectomy for lung cancer Source: Virtual Congress 2021 – Thoracic surgery, lung cancer and complications of COVID-19 Year: 2021
Surgical treatment of right middle lobe syndrome in children Source: Annual Congress 2008 - Actual challenges in thoracic surgery Year: 2008
Patients of combined small cell low-differentiated non-small cell lung carcinoma metastatic to left eye lateral rectus muscle and clivus Source: Eur Respir J 2006; 28: Suppl. 50, 93s Year: 2006
Effect of fissure integrity on the efficacy of bronchoscopic lung volume reduction therapy using a peripheral acting tissue sealant in patients with advanced upper lobe predominant emphysema Source: Annual Congress 2011 - Treatment beyond inhalers: endoscopic lung volume reduction Year: 2011
Single session bilateral endoscopic lung volume reduction therapy in advanced upper lobe and homogeneous emphysema using a tissue sealant Source: Annual Congress 2011 - Endoscopic lung volume reduction: hype or hope? Year: 2011
Adjuvant chemotherapy and prophylactic cranial irradiation in the combined treatment for the operable patients with small cell lung cancer I-III stage Source: Eur Respir J 2005; 26: Suppl. 49, 75s Year: 2005
Surgical and survival outcomes of sleeve lobectomy after neoadjuvant theraphy in lung cancer: With group of 265 patients Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021
Outcome after pneumonectomy in non small cell lung cancer patients receiving a neoadjuvant therapy Source: Eur Respir J 2004; 24: Suppl. 48, 478s Year: 2004
SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection Source: Eur Respir J, 56 (5) 2000118; 10.1183/13993003.00118-2020 Year: 2020
Symptom control and objective response due to palliative therapy of NSCLC brain metastases – 68 cases Source: Eur Respir J 2006; 28: Suppl. 50, 751s Year: 2006
Role of radiotherapy in the tretment of superior vena cava syndrome caused by lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 74s Year: 2004
Short-term efficacy of advanced NSCLC patients receiving anlotinib hydrochloride as the first and second-line treatment Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020
A case of haemoptysis and bilateral areas of lung consolidation sparing the right lower lobe Source: Breathe, 17 (4) 210072; 10.1183/20734735.0072-2021 Year: 2021
Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour Source: Eur Respir J 2007; 29: 117-126 Year: 2007
FDG-PET is superior to conventional CT in predicting histologic responses after induction therapy for locally advanced NSCLC Source: Annual Congress 2010 - Staging of lung cancer Year: 2010
The surgical treatment of patients with lung metastases Source: Eur Respir J 2004; 24: Suppl. 48, 42s Year: 2004